A Phase Ia Clinical Study of QLF31907 Injection in Patients With Advanced Malignant Tumors

NCT05150405 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor
Lymphoma, Non-Hodgkin

Interventions

DRUG: QLF31907

Sponsor

Qilu Pharmaceutical Co., Ltd.